Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%
ERICKSON AIR EAC
5.10%
ASSURED GUAR AGO
4.98%

Ventas Makes Strategic Move on Atria

by Zacks Equity Research

December 28, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Ventas, Inc. (VTR - Analyst Report) a leading health care real estate investment trust (REIT), has recently accomplished a deal by which the company along with the management team of Atria Senior Living, Inc. gained complete ownership over Atria.

Ventas executed the deal through the acquisition of 100% of several private investment funds formerly managed by Lazard Frères Real Estate Investors LLC (‘LFREI’) or its affiliates. Funds acquired now possess a 34% interest in Atria and 3.7 million shares of Ventas common stock. The amount required for this purchase of interests was around $242 million. Notably, executives and employees of Atria have a 66% stake in Atria.

Atria will carry on managing a portfolio of 118 private pay senior living communities comprising around 13,600 units for Ventas, which are situated in major metropolitan markets.

The Back Story

In May 2011, Ventas substantially acquired all of the real estate assets and working capital of privately-owned Atria Senior Living Group Inc. (ASLG). However, at that time, private equity funds managed by LFREI or its affiliates owned ASLG.

Before the closing of the deal, ASLG spun off its management operations to a newly formed entity named Atria Senior Living Inc., which continued to be substantially owned and controlled by LFREI or its affiliates. Post-acquisition, Atria continues to manage these properties.

In Conclusion

Ventas, primarily engaged in the business of financing, owning and leasing healthcare related and senior housing facilities, boasts one of the largest and most diversified portfolios in the healthcare sector with exposure to all types of facilities.

The product diversity of the company allows it to capitalize on opportunities in different markets based on individual market dynamics, and provides a hard-to-replicate competitive advantage over its peers. This recent transaction further creates additional growth prospects.

Ventas received specific rights and minority protections concerning material transactions impacting Atria and is permitted two seats on Atria’s board. Further, Ventas put an end to its commitment related to the “Earnout,” a contingent performance-based payment that resulted from Ventas’s 2011 acquisition of 117 Atria-managed senior living communities, for an additional $44 million. However, this transaction is likely to be minimally accretive to Ventas’s 2013 normalized funds from operations (FFO) per share.

Ventas currently retains a Zacks #2 Rank, which translates into a short-term Buy rating. One of its competitors, HCP, Inc (HCP - Analyst Report) currently retains a Zacks #3 Rank, which translates into a short-term Hold rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.